Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis.

2.50
Hdl Handle:
http://hdl.handle.net/10143/110914
Title:
Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis.
Authors:
Hov, Johannes R; Keitel, Verena; Laerdahl, Jon K; Spomer, Lina; Ellinghaus, Eva; Elsharawy, Abdou; Melum, Espen; Boberg, Kirsten M; Manke, Thomas; Balschun, Tobias; Schramm, Christoph; Bergquist, Annika; Weismüller, Tobias; Gotthardt, Daniel; Rust, Christian; Henckaerts, Liesbet; Onnie, Clive M; Weersma, Rinse K; Sterneck, Martina; Teufel, Andreas; Runz, Heiko; Stiehl, Adolf; Ponsioen, Cyriel Y; Wijmenga, Cisca; Vatn, Morten H; Stokkers, Pieter C F; Vermeire, Severine; Mathew, Christopher G; Lie, Benedicte A; Beuers, Ulrich; Manns, Michael P; Schreiber, Stefan; Schrumpf, Erik; Häussinger, Dieter; Franke, Andre; Karlsen, Tom H
Citation:
PloS one 2010, 5 (8)
Additional Links:
http://www.ncbi.nlm.nih.gov/sites/entrez

Full metadata record

DC FieldValue Language
dc.contributor.authorHov, Johannes Ren
dc.contributor.authorKeitel, Verenaen
dc.contributor.authorLaerdahl, Jon Ken
dc.contributor.authorSpomer, Linaen
dc.contributor.authorEllinghaus, Evaen
dc.contributor.authorElsharawy, Abdouen
dc.contributor.authorMelum, Espenen
dc.contributor.authorBoberg, Kirsten Men
dc.contributor.authorManke, Thomasen
dc.contributor.authorBalschun, Tobiasen
dc.contributor.authorSchramm, Christophen
dc.contributor.authorBergquist, Annikaen
dc.contributor.authorWeismüller, Tobiasen
dc.contributor.authorGotthardt, Danielen
dc.contributor.authorRust, Christianen
dc.contributor.authorHenckaerts, Liesbeten
dc.contributor.authorOnnie, Clive Men
dc.contributor.authorWeersma, Rinse Ken
dc.contributor.authorSterneck, Martinaen
dc.contributor.authorTeufel, Andreasen
dc.contributor.authorRunz, Heikoen
dc.contributor.authorStiehl, Adolfen
dc.contributor.authorPonsioen, Cyriel Yen
dc.contributor.authorWijmenga, Ciscaen
dc.contributor.authorVatn, Morten Hen
dc.contributor.authorStokkers, Pieter C Fen
dc.contributor.authorVermeire, Severineen
dc.contributor.authorMathew, Christopher Gen
dc.contributor.authorLie, Benedicte Aen
dc.contributor.authorBeuers, Ulrichen
dc.contributor.authorManns, Michael Pen
dc.contributor.authorSchreiber, Stefanen
dc.contributor.authorSchrumpf, Eriken
dc.contributor.authorHäussinger, Dieteren
dc.contributor.authorFranke, Andreen
dc.contributor.authorKarlsen, Tom Hen
dc.date.accessioned2010-09-09T11:16:38Z-
dc.date.available2010-09-09T11:16:38Z-
dc.date.issued2010-
dc.identifier.citationPloS one 2010, 5 (8)en
dc.identifier.issn1932-6203-
dc.identifier.pmid20811628-
dc.identifier.doi10.1371/journal.pone.0012403-
dc.identifier.urihttp://hdl.handle.net/10143/110914-
dc.description.abstractBACKGROUND: TGR5, the G protein-coupled bile acid receptor 1 (GPBAR1), has been linked to inflammatory pathways as well as bile homeostasis, and could therefore be involved in primary sclerosing cholangitis (PSC) a chronic inflammatory bile duct disease. We aimed to extensively investigate TGR5 sequence variation in PSC, as well as functionally characterize detected variants. METHODOLOGY/PRINCIPAL FINDINGS: Complete resequencing of TGR5 was performed in 267 PSC patients and 274 healthy controls. Six nonsynonymous mutations were identified in addition to 16 other novel single-nucleotide polymorphisms. To investigate the impact from the nonsynonymous variants on TGR5, we created a receptor model, and introduced mutated TGR5 constructs into human epithelial cell lines. By using confocal microscopy, flow cytometry and a cAMP-sensitive luciferase assay, five of the nonsynonymous mutations (W83R, V178M, A217P, S272G and Q296X) were found to reduce or abolish TGR5 function. Fine-mapping of the previously reported PSC and UC associated locus at chromosome 2q35 in large patient panels revealed an overall association between the TGR5 single-nucleotide polymorphism rs11554825 and PSC (odds ratio = 1.14, 95% confidence interval: 1.03-1.26, p = 0.010) and UC (odds ratio = 1.19, 95% confidence interval 1.11-1.27, p = 8.5x10(-7)), but strong linkage disequilibrium precluded demarcation of TGR5 from neighboring genes. CONCLUSIONS/SIGNIFICANCE: Resequencing of TGR5 along with functional investigations of novel variants provided unique insight into an important candidate gene for several inflammatory and metabolic conditions. While significant TGR5 associations were detected in both UC and PSC, further studies are needed to conclusively define the role of TGR5 variation in these diseases.en
dc.languageENG-
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/sites/entrezen
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologi: 773en
dc.titleMutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis.-
dc.typeJournal articleen
dc.typepeer revieweden
dc.contributor.departmentNorwegian PSC Research Center, Clinic for Specialized Medicine and Surgery, Oslo University Hospital Rikshospitalet, Oslo, Norway.en
dc.identifier.journalPloS oneen
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.